The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing Yousef A. AbdelradyHayam S. ThabetAhmed M. Sayed Review 21 October 2024 Pages: 1 - 20
Long noncoding RNA MEG3: an active player in fibrosis Xiaoying Jiang Review 07 October 2024 Pages: 21 - 30
Acyclic sesquiterpenes nerolidol and farnesol: mechanistic insights into their neuroprotective potential Anish SinghLovedeep Singh Review 22 October 2024 Pages: 31 - 42
Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities Fatemeh AskarizadehSercan KaravAmirhossein Sahebkar Review 16 December 2024 Pages: 43 - 71
Ursolic acid in colorectal cancer: mechanisms, current status, challenges, and future research directions Huici ZhangXiaoyu ZhangXuan Wang Review 02 December 2024 Pages: 72 - 86
Anticancer potential of osthole: targeting gynecological tumors and breast cancer Yingqi HanZhengao Sun Review 02 December 2024 Pages: 87 - 102
A comprehensive update on the potential of curcumin to enhance chemosensitivity in colorectal cancer Mahdi ShadnoushMehrnaz MomenanMakan Cheraghpour Review 20 September 2024 Pages: 103 - 123
Progress in the study of anti-tumor effects and mechanisms of vitexin Qiming YangRui HuanLei Xia Review 31 October 2024 Pages: 124 - 134
Assessing the effects of 5-HT2A and 5-HT5A receptor antagonists on DOI-induced head-twitch response in male rats using marker-less deep learning algorithms Ewelina CyranoPiotr Popik Research Open access 27 November 2024 Pages: 135 - 144
Proteomics analysis in rats reveals convergent mechanisms between major depressive disorder and dietary zinc deficiency Łukasz GąsiorBartłomiej PochwatBernadeta Szewczyk Research Open access 03 December 2024 Pages: 145 - 157
Advanced pharmacological and pharmacokinetic evaluation of 1,3 dimethylpurine-2,6-dione derivative (GR-14) with prominent mood-modulating activity in rats Agnieszka CiosGrażyna Chłoń-RzepaAnna Wesołowska Research 16 December 2024 Pages: 158 - 171
Select terpenes from Cannabis sativa are antinociceptive in mouse models of post-operative pain and fibromyalgia via adenosine A2a receptors Caleb A. SeekinsAlyssa M. WelbornJohn M. Streicher Research 12 December 2024 Pages: 172 - 181
c-Myc inhibition and p21 modulation contribute to unsymmetrical bisacridines-induced apoptosis and senescence in pancreatic cancer cells Agnieszka KurdynMonika PawłowskaEwa Augustin Research Open access 03 October 2024 Pages: 182 - 209
Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma Agnieszka RusakMarlena Gąsior-GłogowskaPiotr Dzięgiel Research Open access 14 November 2024 Pages: 210 - 228
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoids Alissar MonzerFatima GhamloucheWassim Abou-Kheir Research 18 November 2024 Pages: 229 - 246
Effects of puerarin on gait disturbance in a 6-hydroxydopamine mouse model of Parkinson’s disease Na-Hyun KimYukiori GotoYoung-A Lee Research 28 October 2024 Pages: 247 - 259
JG26 attenuates ADAM17 metalloproteinase-mediated ACE2 receptor processing and SARS-CoV-2 infection in vitro Valentina GentiliSilvia BeltramiElisa Nuti Research Open access 18 September 2024 Pages: 260 - 273
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database Annamaria MascoloAlessia ZinziAnnalisa Capuano Research 23 October 2024 Pages: 274 - 286
A hydrogen sulphide-releasing non-steroidal anti-inflammatory, ATB-346, significantly attenuates human myometrial contractions Ana MijuškovićSusan WraySarah Arrowsmith Short Communication Open access 04 September 2024 Pages: 287 - 294
Novel fluorinated cannabinoid analogs modulate cytokine expression in human C20 microglial cells Randall L. DavisSascha GrotjahnJimmie D. Weaver III Brief Communication 29 November 2024 Pages: 295 - 301